LH-RH Agonists in the Treatment of Metastatic Breast Cancer: Five Years Experience

This publication has 22 references indexed in Scilit:

• Combined effects of Buserelin, estradiol and Tamoxifen on the growth of MCF-7 human breast cancer cells in vitro
  Biochemical and Biophysical Research Communications, 1986
• Remissions of metastatic breast cancer in post-menopausal women with luteinising hormone releasing hormone (ICI 118630) therapy
  European Journal of Cancer and Clinical Oncology, 1986
• Buserelin in treatment of premenopausal advanced breast cancer
  European Journal of Cancer and Clinical Oncology, 1986
• Phase II trial of D-Trp-6-LH-RH in advanced breast cancer
  European Journal of Cancer and Clinical Oncology, 1986
• Direct inhibitory effect of a luteinizing hormone-releasing hormone agonist on MCF-7 human breast cancer cells
  European Journal of Cancer and Clinical Oncology, 1985
• Anti-tumor and endocrine effects of chronic LHRH agonist treatment (Buserelin) with or without tamoxifen in premenopausal metastatic breast cancer
  Breast Cancer Research and Treatment, 1984
• LHRH-agonist treatment in metastatic prostate carcinoma
  European Journal of Cancer and Clinical Oncology, 1984
• 286 An analogue of LHRH antagonizes the growth-stimulating effect of oestradiol on human breast cancer cells in culture (MCF-7)
  Journal of Steroid Biochemistry, 1983
• Revision of the standards for the assessment of hormone receptors in human breast cancer; report of the second E.O.R.T.C. workshop, held on 16–17 March, 1979, in the Netherlands Cancer Institute
  Published by Elsevier ,1980
• Effects of a gonadotropin-releasing hormone (GnRH) analogue (A-43818) on7,12-dimethylbenz(a)anthracene-induced rat mammary tumors. Histological and endocrine studies
  Published by Elsevier ,1977